MMWR Morb Mortal Wkly Rep. 2022 Aug 26;71(34):1073-1080. doi: 10.15585/mmwr.mm7134a1.
The number of nonfatal opioid-involved overdoses treated by health care providers has risen in the United States; the median number of emergency department (ED) visits for these overdoses was significantly higher during 2020 than during 2019 (1). ED visit data can underestimate nonfatal opioid-involved overdose incidence because, increasingly, persons experiencing a nonfatal opioid overdose are refusing transport to EDs by emergency medical services (EMS) (2). A study in Kentucky found that during a 6-month period, 19.8% of persons treated by EMS for an opioid overdose refused transport to an ED (2). Thus, EMS encounter data involving suspected nonfatal opioid-involved overdoses complement ED data and also allow for near real-time analysis (3). This report describes trends in rates of EMS encounters for nonfatal opioid-involved overdoses per 10,000 total EMS encounters (rates) by selected patient- and county-level characteristics during January 2018–March 2022 in 491 counties from 21 states using data from biospatial, Inc.* During this period, the nonfatal opioid-involved overdose rate increased, on average, 4.0% quarterly. Rates increased for both sexes and for most age groups. Rates were highest among non-Hispanic White (White) and non-Hispanic Native Hawaiian or other Pacific Islander (NH/OPI) persons, and increases were largest among non-Hispanic Black (Black), followed by Hispanic or Latino (Hispanic) persons. Rates increased in both urban and rural counties and for all quartiles of county-level characteristics (i.e., unemployment, education, and uninsured), except in counties with the lowest percentage of uninsured persons. Rates were highest and rate increases were largest in urban counties and counties with higher unemployment rates. This analysis of nonfatal opioid-involved overdose trends in EMS data highlights the utility of these data and the importance of addressing inequities that contribute to disproportionate overdose risk, such as through focused outreach to racial and ethnic minority groups, who disproportionately experience these inequities, and communities with higher levels of unemployment. EMS providers are in a unique position to engage in postoverdose response protocols and promote evidence-based overdose education and facilitate linkage to care and harm reduction services.†,§
美国卫生保健提供者治疗的非致命类阿片药物过量的人数有所增加;与 2019 年相比,2020 年因这些过量而到急诊部(ED)就诊的中位数数量显著更高(1)。ED 就诊数据可能低估了非致命类阿片药物过量的发生率,因为越来越多经历非致命类阿片药物过量的人拒绝由紧急医疗服务(EMS)转运到 ED(2)。肯塔基州的一项研究发现,在六个月的时间里,19.8%的 EMS 治疗阿片类药物过量的患者拒绝转运到 ED(2)。因此,涉及疑似非致命类阿片药物过量的 EMS 接触数据补充了 ED 数据,并且还允许进行近乎实时的分析(3)。本报告描述了 2018 年 1 月至 2022 年 3 月期间,21 个州的 491 个县,根据患者和县级特征,每 10000 次 EMS 接触中非致命类阿片药物过量 EMS 接触的比率(速率)趋势,使用来自 biospatial,Inc. 的生物空间数据*在此期间,非致命类阿片药物过量的比率平均每季度增长 4.0%。男女和大多数年龄组的比率都有所上升。非西班牙裔白人(白人)和非西班牙裔夏威夷原住民或其他太平洋岛民(NH/OPI)的比率最高,非西班牙裔黑人(黑人)的增幅最大,其次是西班牙裔或拉丁裔(西班牙裔)。城乡县以及县级特征(即失业率、教育程度和未参保人数)的所有四分位数的比率都有所上升,除了未参保人数比例最低的县。在城市县和失业率较高的县,比率最高,增长率最大。这项对 EMS 数据中非致命类阿片药物过量趋势的分析强调了这些数据的实用性,以及解决导致不成比例的过量风险的不平等问题的重要性,例如通过针对过度经历这些不平等的种族和族裔少数群体以及失业率较高的社区进行有针对性的外展。EMS 提供者处于独特的地位,可以参与过量后反应方案,并促进基于证据的过量教育,并促进与护理和减少伤害服务的联系。†,§